Mobile Smoking Treatment for Hispanic Individuals Who Smoke
- Conditions
- Smoking Cessation
- Interventions
- Behavioral: Impacto (Mobile App)
- Registration Number
- NCT06586034
- Lead Sponsor
- University of Houston
- Brief Summary
The specific aims of the project are to develop and test a mobile application for smoking cessation for Hispanic individuals who smoke called Impacto.
- Detailed Description
A total of 56 Hispanic individuals who smoke will be recruited for this project. Six (6) participants will complete usability/functionality testing of Impacto 2.0 in the English language for both iOS and Android. Following usability/functionality testing, a field test with 50 adult Hispanic individuals who smoke (50% English-speaking and 50% Spanish-speaking) will be recruited nationally and will receive Impacto 2.0 (50% Android and iOS platforms).
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 56
-
- being Hispanic, 2) at least 18 years of age, 2) currently smoking (i.e., at least 5 cigarettes/day) biochemically verified by a CO > 7, 3), meeting criteria for high AS (cut-off score of 5 on the Short Scale Anxiety Sensitivity Index), 4) motivation to quit > 5 on a 10 pt. scale, 5) able to provide informed consent, 6) has daily access to their own iPhone or Android smartphone, and 7) is a fluent English or Spanish speaker.
-
- current participation in substance abuse treatment, 2) in psychotherapy for anxiety or depression, 3) concurrent use of medication for anxiety or depression, 4) active suicidality (ideation, intent, and/or plan), or 5) current psychosis.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Impacto Impacto (Mobile App) This is the mobile application to be developed and evaluated in this project.
- Primary Outcome Measures
Name Time Method 7-Day Point Prevalence Smoking Abstinence End of treatment (Week 8) 7-day point prevalence smoking status (verification via carbon monoxide).
- Secondary Outcome Measures
Name Time Method Anxiety Sensitivity Baseline, week 4, and end of treatment (Week 8) Anxiety sensitivity will be assessed using the Short Scale Anxiety Sensitivity Index (SSASI).